Results 171 to 180 of about 724,601 (205)

Epidemiology of antifungal susceptibility: Review of literature

Journal de Mycologie Médicale, 2018
Fungal infections are a major cause of morbidity and mortality despite the latest developments of diagnostic tools and therapeutic options. Early initiation of the appropriate antifungal therapy has been demonstrated to have a direct impact on the patient's outcome. Antifungal susceptibility testing methods are available to detect antifungal resistance
I, Hadrich, A, Ayadi
openaire   +2 more sources

Antifungal Susceptibility Testing in Teaching Hospitals

Annals of Pharmacotherapy, 2003
BACKGROUND: An assessment of antifungal susceptibility testing (AST) has not been conducted since the introduction of the National Committee for Clinical Laboratory Standards (NCCLS) M27-A document. OBJECTIVE: To determine AST ...
Manjunath P, Pai, Susan L, Pendland
openaire   +2 more sources

Antifungal Susceptibility Testing: The Times They Are A-Changing

Clinical Microbiology Newsletter, 2019
Antifungal susceptibility testing (AFST) has never been as mainstream as antibacterial susceptibility testing. That may soon change. We are in an unprecedented era of antifungal development which could change the usefulness of and demand for AFST. Here we lay out an argument for increased AFST capacity, discuss new antifungals that are likely to appear
Shawn R, Lockhart, Elizabeth L, Berkow
openaire   +2 more sources

Antifungal Drug Susceptibility Testing

1989
The continuing introduction of new antifungal drugs has increased the demand for methods of in vitro testing that can predict the effects of compounds in vivo. As with antibacterial drugs, tests designed to ascertain the minimum amount of drug needed to inhibit the growth of organisms in vitro (minimum inhibitory concentration, or MIC) have often been ...
openaire   +2 more sources

Pathogenicity and antifungal susceptibility ofChaetomium species

European Journal of Clinical Microbiology & Infectious Diseases, 1995
Several reports have been published implicating Chaetomium spp. as opportunistic pathogens. A critical review of these cases was made, and the majority of the responsible strains were studied. Chaetomium globosum was the most common species, being isolated in at least nine clinical cases of infection.
J, Guarro, L, Soler, M G, Rinaldi
openaire   +2 more sources

Antifungal drug susceptibility testing

Mycopathologia, 1984
The advent of new antifungal drugs provides clinicians with therapeutic options, and it is anticipated requests for fungal susceptibility testing in vitro will increase. Our own laboratory's experience indicates that results can be provided promptly even to distant medical centers.
openaire   +2 more sources

Progress in Standardizing Antifungal Susceptibility Tests

Clinics in Laboratory Medicine, 1989
In vitro tests of antifungal agents are receiving increasing attention as important procedures for the clinical laboratory. As antifungal agents proliferate, it will become more and more valuable to have available antifungal susceptibility tests to aid in treatment selections based on the specific activities of different drugs against a patient's own ...
openaire   +2 more sources

Antifungal susceptibility testing with dermatophytes

Mycoses, 1991
Summary. The determination of the in vitro activity of antimycotics against dermatophytes has for long been considered as irrelevant from a practical point of view. Recently, however, this approach has been questioned. Various different tests such as agar diffusion test, agar dilution test and broth dilution test can be used for the determination of ...
Aletta Georgii, H. C. Korting
openaire   +1 more source

Etest for antifungal susceptibility testing of yeasts

Diagnostic Microbiology and Infectious Disease, 1994
Comparison [+/- 1 dilution between minimum inhibitory concentrations (MICs)] of fluconazole and flucytosine Etest MICs of 10 candidate quality control yeast isolates and 78 clinical isolates demonstrated good agreement (> or = 90%) with the reference method (National Committee for Clinical Laboratory Standards document M27-P).
openaire   +2 more sources

Antifungal drug susceptibility testing

Medical Mycology, 1994
J, Van Cutsem, H, Kurata, H, Matsuoka, Y, Mikami, M A, Pfaller, G M, Scalarone, M G, Rinaldi   +6 more
openaire   +2 more sources